The feasibility of using pathobiome strains as live biotherapeutic products for human use

Pengfei Jin1, Xiong Lin2, Wenfeng Xu1

  • 1Department of Pharmacy Beijing Hospital, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences; Beijing Key Laboratory of Assessment of Clinical Drugs Risk and Individual Application (Beijing Hospital) Beijing China.

Imeta
|June 20, 2024
PubMed